From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Pfizer medication for juvenile arthritis

from The Weekly Journal

Pfizer Inc. announced that the U.S. Food and Drug Administration approved XELJANZ for the treatment of children and adolescents two years and older with active polyarticular course juvenile idiopathic arthritis. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063